Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new study-record version was submitted on November 2, 2026, documenting a change to the study status.SummaryDifference0.1%

- Check16 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check23 days agoChange DetectedA banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.3%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check37 days agoChange DetectedThe website footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check51 days agoChange DetectedNew version entries were added to the study history with updates to Study Status and Contacts/Locations. An older version was removed, signaling ongoing maintenance of the trial record.SummaryDifference0.3%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.